Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma

Journal of Oral Pathology & Medicine

Volumn 23, Issue 6, 1994, Pages 246-250

  Warnakulasuriya, K A A S ^a   Johnson, Newell W ^a  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

epithelial cell proliferation; immunohistochemistry; Ki 67; oral carcinoma; p53; PCNA

Indexed keywords

EID: 0028467172     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1994.tb00053.x     Document Type: Article

References (43)

1. The p53 tumour suppressor gene and product
2. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinomas of the head and neck
3. Expression of p53 in pre‐malignant and malignant squamous cell epithelium
4. Assessment of p53 protein expression in normal, benign and malignant oral mucosa
5. Expression of p53 mutant nuclear oncoprotein in oral carcinoma and potentially malignant oral lesions
6. P53: oncogene or anti‐oncogene
7. p53 in the diagnosis of human neoplasia
8. Biochemical, immunological, and functional aspects of the growth‐suppressor/oncoprotein p53
9. Presence of a potent transcription activating sequence in the p53 protein
10. The p53 tumour suppressor gene
11. P53. guardian of the genome
12. The role of p53 in the normal control of cell proliferation
13. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects
14. Comparison of isotopic and immunohistochemical methods to study cell kinetics
15. The application of immunohistochemistry in assessment of cellular proliferation
16. Structural indicators of the high risk lesion
17. Quantitative histological changes during early experimental carcinogenesis in hamster cheek pouch
18. Cloning and characterization of a EDNA from Xenopus Laens coding a protein homologous to human and murine p53
19. p53 gene mutations in human gastric cancer: wild‐type of p53 but not mutant p53 suppresses growth of human gastric cancer cells
20. Tumor suppressor genes
21. p53 in tumour pathology: can we trust immunohistochemistry
22. Amplification of a gene encoding a p53‐associated protein in human sarcomas
23. Cell cycle‐related staining patterns of anti–proliferating cell nuclear antigen monoclonal antibodies. Comparison of BrdU labelling and Ki‐67 staining
24. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms
25. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma
26. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers
27. Proliferating cell nuclear antigen in malignant and pre‐malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study
28. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers
29. Cell kinetics and response to primary intra‐arterial chemotherapy in patients with advanced oral cavity tumours
30. In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity
31. Lack of relationship between the expression of proliferating cell nuclear antigen (PCNA), Ki67 antigen and p53 protein in squamous cell carcinoma of the bronchus: an immunohistochemical study
32. p53 expression in breast cancer
33. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki‐67 labelling in brain tumours
34. Growth suppression induced by wild‐type p53 protein is accompanied by selective down‐regulation of proliferating‐cell nuclear antigen expression
35. The relationship of p53 over‐accumulation to tumour proliferation and tumour grade in breast carcinomas
36. p53 protein expression in central nervous system neoplasms
37. Association of overexpression of tumour suppressor protein p53 with rapid cell proliferation and poor prognosis in node‐negative breast cancer patients
38. Over‐expression of p53 nuclear oncoprotein in colorectal adenomas
39. p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters
40. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
41. Biochemical properties of the growth suppressor/oncoprolein p53
42. Oncogenes, growth, and the cell cycle: an overview
43. The future of prognostic factors in outcome prediction for patients with cancer